Clinical Trial Update: BETAmethasone Dose Reduction: Non-Inferiority on the Neurocognitive Outcomes of Children Born Before 32 Weeks of Gestation [NA]

View source ↗

Summary

A clinical trial evaluating whether a reduced dose of betamethasone in pregnancies delivering before 32 weeks is non-inferior for neurocognitive outcomes in the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• betamethasone (betamethasone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Premature Childbirth | NA | Status: RECRUITING